Mark Genovese
0000-0001-5294-4503
3 papers found
Refreshing results…
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III , Double‐Blind, Randomized Controlled Trial
Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response
Missing publications? Search for publications with a matching author name.